Drugs / TransCon Treprostinil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03803163 | Jan → Jun 2015 | — | Ascendis Pharma A/S | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TransCon Treprostinil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03803163 ↗ |
| Route | Subcutaneous | “administered as a subcutaneous injection” NCT03803163 ↗ |